The Lung Transplant Program at Baylor University Medical Center, part of Baylor Scott & White Health provides advanced treatment and personalized, quality care for patients with end-stage lung disease.
Our Dallas lung transplant team includes world-renowned experts in thoracic surgery and pulmonary medicine. The attentive physicians on the medical staff at Baylor University Medical Center bring a wealth of knowledge and depth of experience to the care of patients. We pride ourselves on close and ongoing communication with referring physicians, and we are dedicated to meticulous follow-up.
In addition, Baylor University Medical Center in Dallas is home to one of the busiest adult extra corporeal membrane oxygenation (ECMO) programs in North Texas and the region's only ECMO deployment program. Baylor University Medical Center is ranked as one of America's top hospitals by U.S. News & World Report.
The Center for Advanced Heart and Lung Disease provides diagnosis and comprehensive treatment of individuals with chronic lung disease, connective tissue disease, cystic fibrosis, interstitial lung disease and pulmonary fibrosis. We perform advanced diagnostic procedures and highly specialized evaluations for the proper identification and treatment of complex lung disorders. The treatment team including physicians who specialize in advanced lung disease consults together with other medical, surgical and pulmonary rehabilitation specialists to devise a treatment plan that gives hope for our patients to receive the best possible outcome and improved quality of life.
Among the advanced treatments and clinical research provided are:
Once Lorenzo was diagnosed with idiopathic pulmonary fibrosis (IPF), the simple act of breathing became more and more difficult. But Baylor Scott & White Health acted quickly helping Lorenzo throughout the entire journey from finding a donor to undergoing surgery to making a full recovery.
Today, Lorenzo cherishes every breath he takes.
In North Texas, Baylor University Medical Center, part of Baylor Scott & White Health, in Dallas has one of the busiest multi-specialty organ transplant systems in the world—the Baylor Annette C. and Harold C. Simmons Transplant Institute.
Teams of physicians, nurses and assistants travel to outreach clinics throughout Texas to deliver world-renowned transplantation medicine to an expanding network of communities. Both initial organ transplant evaluation and post-transplant follow-up appointments are available.
At Baylor University Medical Center, patients have access to many innovative clinical trials. Our advanced lung disease and lung transplantation team in Dallas is dedicated to advancing the field through a robust research program. We have multiple ongoing trials and research studies, including pharmaceutical and biologics industry-directed trials, translational clinical research studies and institutional-based clinical and translational research studies.
Areas under investigation include identification of serum markers that diagnose rejection after lung transplant and the use of novel anti-rejection medication to treat early and established chronic rejection after lung transplant. Other questions being studied relate to immune suppression, infection, lung rejection, lung fibrosis, the genetics of lung disease, the use of anticoagulation in extracorporeal support, and new pulmonary hypertension treatments and asthma therapies.
